首页> 外文OA文献 >Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.
【2h】

Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.

机译:单次口服组胺H1拮抗剂通过正电子发射断层扫描测量后,人脑中的组胺H1受体占有率。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

1. Histamine H1 receptor occupancy in the human brain was measured in 20 healthy young men by positron emission tomography (PET) using [11C]-doxepin. 2. (+)-Chlorpheniramine, a selective and classical antihistamine, occupied 76.8 +/- 4.2% of the averaged values of available histamine H1 receptors in the frontal cortex after its administration in a single oral dose of 2 mg. Intravenous administration of 5 mg (+)-chlorpheniramine almost completely abolished the binding of [11C]-doxepin to H1 receptors (H1 receptor occupancy: 98.2 +/- 1.2%). 3. Terfenadine, a nonsedative antihistamine, occupied 17.2 +/- 14.2% of the available H1 receptors in the human frontal cortex after its administration in a single oral dose of 60 mg. 4. There was no correlation between H1 receptor occupancy by terfenadine and the plasma concentration of the active acid metabolite of terfenadine in each subject. 5. PET data on human brain were essentially compatible with those on H1 receptor occupancy in guinea-pig brain determined by in vivo binding techniques, although for the same H1 receptor occupancy the dose was less in human subjects than in guinea-pigs. 6. The PET studies demonstrated the usefulness of measuring H1 receptor occupancy with classical and second-generation antihistamines in human brain to estimate their unwanted side effects such as sedation and drowsiness quantitatively.
机译:1.使用[11C]-多塞平通过正电子发射断层扫描(PET)测量了20名健康年轻人中组胺H1受体在人脑中的占有率。 2.(+)-氯苯那敏是一种选择性的经典抗组胺药,单次口服2 mg后,其额叶皮质中可用的组胺H1受体平均值占平均值的76.8 +/- 4.2%。静脉注射5 mg(+)-氯苯那敏几乎完全消除了[11C] -doxepin与H1受体的结合(H1受体占有率:98.2 +/- 1.2%)。 3.特非那定是一种非镇静性抗组胺药,单次口服60毫克后,其在人类额叶皮层中占有可用H1受体的17.2 +/- 14.2%。 4.在每个受试者中,特非那定的H1受体占有率与特非那定的活性酸代谢产物的血浆浓度之间没有相关性。 5.关于人脑的PET数据与通过体内结合技术确定的豚鼠脑中H1受体占有率的数据基本相符,尽管对于相同的H1受体占有率,人受试者的剂量要小于豚鼠。 6. PET研究表明,在人脑中测量经典和第二代抗组胺药对H1受体的占有率可用于定量估计其不良镇静和嗜睡等副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号